These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31583380)

  • 1. The Role of Anti-Obesity Medication in Prevention of Diabetes and Its Complications.
    Oh TJ
    J Obes Metab Syndr; 2019 Sep; 28(3):158-166. PubMed ID: 31583380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting.
    Leventhal-Perek S; Shani M; Schonmann Y
    Fam Pract; 2023 Dec; 40(5-6):629-637. PubMed ID: 36477550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of obesity in pediatric patients.
    Boland CL; Harris JB; Harris KB
    Ann Pharmacother; 2015 Feb; 49(2):220-32. PubMed ID: 25366340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T; Shukla AP; Saunders KH; Aronne LJ
    Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Long-Term Pharmacotherapies for the Management of Obesity.
    Kim BY; Kang SM; Kang JH; Kim KK; Kim B; Kim SJ; Kim YH; Kim JH; Kim JH; Nam GE; Park JY; Son JW; Shin HJ; Oh TJ; Lee H; Jeon EJ; Chung S; Hong YH; Kim CH;
    J Obes Metab Syndr; 2020 Jun; 29(2):99-109. PubMed ID: 32378399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorcaserin for weight management.
    Taylor JR; Dietrich E; Powell J
    Diabetes Metab Syndr Obes; 2013; 6():209-16. PubMed ID: 23788837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.
    Andrew CA; Saunders KH; Shukla AP; Aronne LJ
    Expert Opin Pharmacother; 2019 Apr; 20(5):585-593. PubMed ID: 30614740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity Therapy: How and Why?
    Paccosi S; Cresci B; Pala L; Rotella CM; Parenti A
    Curr Med Chem; 2020; 27(2):174-186. PubMed ID: 30678612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.
    Maetzel A; Ruof J; Covington M; Wolf A
    Pharmacoeconomics; 2003; 21(7):501-12. PubMed ID: 12696990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of obesity: Available medications and drugs under investigation.
    Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS
    Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
    Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
    JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of pharmacologic treatment for pediatric obesity.
    Chao AM; Wadden TA; Berkowitz RI
    Expert Opin Drug Saf; 2018 Apr; 17(4):379-385. PubMed ID: 29411652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging pharmacotherapies for obesity in Australia.
    Hocking S; Dear A; Cowley MA
    Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery.
    Fabbrini E; Klein S
    Clin Cornerstone; 2008; 9(1):41-8; discussion 49-51. PubMed ID: 19046739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity Pharmacotherapy.
    Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
    Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity.
    Saunders KH; Kumar RB; Igel LI; Aronne LJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):36. PubMed ID: 27181165
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.